{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T14:40:34Z","timestamp":1661092834447},"reference-count":31,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2010.0117","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:20:20Z","timestamp":1525252820000},"source":"Crossref","is-referenced-by-count":1,"title":["HIV and Cancer in Germany"],"prefix":"10.3238","author":[{"given":"Manfred","family":"Hensel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Goetzenich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albrecht","family":"Stoehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arend","family":"Moll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Rockstroh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Hanhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Mosthaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2011,2,25]]},"reference":[{"key":"10.3238\/arztebl.2010.0117_ref1","doi-asserted-by":"crossref","unstructured":"Herida M, Mary-Krause M, Kaphan R, et al.: Incidence of non-Aids-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 2003; 21: 3447\u201353.","DOI":"10.1200\/JCO.2003.01.096"},{"key":"10.3238\/arztebl.2010.0117_ref2","doi-asserted-by":"crossref","unstructured":"Lewden C, May T, Rosenthal E, et al.: ANRS EN19 Mortalit\u00e9 Study Group and Mortavic1: Changes in causes of death among adults infected by HIV between 2000 and 2005: The \u201eMortalit\u00e9 2000 and 2005\u201c surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr 2008; 48: 590\u20138.","DOI":"10.1097\/QAI.0b013e31817efb54"},{"key":"10.3238\/arztebl.2010.0117_ref3","doi-asserted-by":"crossref","unstructured":"Bonnet F, Ch\u00eane G, Thi\u00e9baut R, et al.: Groupe d\u2019Epid\u00e9miologie Clinique du SIDA en Aquitaine (GECSA): Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000\u20132004. HIV Med 2007; 8: 547\u201354.","DOI":"10.1111\/j.1468-1293.2007.00508.x"},{"key":"10.3238\/arztebl.2010.0117_ref4","doi-asserted-by":"crossref","unstructured":"Lewden C, Salmon D, Morlat P, et al.: Mortality 2000 study group: Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of Aids. Int J Epidemiol 2005; 34: 121\u201330.","DOI":"10.1093\/ije\/dyh307"},{"key":"10.3238\/arztebl.2010.0117_ref5","doi-asserted-by":"crossref","unstructured":"Bonnet F, Burty C, Lewden C, et al.: Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales EN19 Mortalit\u00e9 Study Group; Mortavic Study Group: Changes in cancer mortality among HIV-infected patients: the Mortalit\u00e9 2005 Survey. Clin Infect Dis 2009; 48: 633\u20139.","DOI":"10.1086\/596766"},{"key":"10.3238\/arztebl.2010.0117_ref6","doi-asserted-by":"crossref","unstructured":"Dal Maso L, Polesel J, Serraino D, et al.: Cancer and Aids Registries Linkage (CARL) Study. Pattern of cancer risk in persons with Aids in Italy in the HAART era. Br J Cancer 2009; 100: 840\u20137.","DOI":"10.1038\/sj.bjc.6604923"},{"key":"10.3238\/arztebl.2010.0117_ref7","doi-asserted-by":"crossref","unstructured":"Spano JP, Costagliola D, Katlama C, Mounier N, Oksenhendler E, Khayat D: Aids-related malignancies: state of the art and therapeutic challenges. J Clin Oncol 2008; 26: 4834\u201342.","DOI":"10.1200\/JCO.2008.16.8252"},{"key":"10.3238\/arztebl.2010.0117_ref8","doi-asserted-by":"crossref","unstructured":"Bonnet F, Ch\u00eane G: Evolving epidemiology of malignancies in HIV. Curr Opin Oncol 2008; 20: 534\u201340.","DOI":"10.1097\/CCO.0b013e32830a5080"},{"key":"10.3238\/arztebl.2010.0117_ref9","doi-asserted-by":"crossref","unstructured":"Hoffmann C, Wolf E, Wyen C, et al.: Aids-associated Burkitt or Burkitt-like lymphoma: short intensive polychemotherapy is feasible and effective. Leuk Lymphoma 2006; 47: 1872\u201380.","DOI":"10.1080\/10428190600685467"},{"key":"10.3238\/arztebl.2010.0117_ref10","doi-asserted-by":"crossref","unstructured":"Hoffmann C, Chow KU, Wolf E, et al.: Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin\u2019s disease. Br J Haematol 2004; 125: 455\u201362.","DOI":"10.1111\/j.1365-2141.2004.04934.x"},{"key":"10.3238\/arztebl.2010.0117_ref11","doi-asserted-by":"crossref","unstructured":"Hentrich M, Maretta L, Chow KU, et al.: Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin\u2019s disease: results of a multicenter study. Ann Oncol 2006; 17: 914\u20139.","DOI":"10.1093\/annonc\/mdl063"},{"key":"10.3238\/arztebl.2010.0117_ref12","doi-asserted-by":"crossref","unstructured":"Hartmann P, Rehwald U, Salzberger B, et al.: BEACOPP therapeutic regimen for patients with Hodgkin\u2019s disease and HIV infection. Ann Oncol 2003; 14: 1562\u20139.","DOI":"10.1093\/annonc\/mdg408"},{"key":"10.3238\/arztebl.2010.0117_ref13","doi-asserted-by":"crossref","unstructured":"Mosthaf FA, Hanhoff NJ, Goetzenich A, Wolf E, Knechten H: Hohe Inzidenz nicht Aids-definierender Neoplasien bei HIV-infizierten Patienten in Deutschland. Ein 3-j\u00e4hriger bundesweiter \u00dcberblick [High incidence of non-Aids-defined cancers among HIV-infected patients in Germany. A 3-year nationwide review]. Dtsch Med Wochenschr 2006; 131: 1849\u201352.","DOI":"10.1055\/s-2006-949167"},{"key":"10.3238\/arztebl.2010.0117_ref14","doi-asserted-by":"crossref","unstructured":"Chow KU, Mitrou PS, Geduldig K, Helm EB, Hoelzer D, Brodt HR: Changing incidence and survival in patients with aids-related non-Hodgkin\u2019s lymphomas in the era of highly active antiretroviral therapy (HAART). Leuk Lymphoma 2001; 41: 105\u201316.","DOI":"10.3109\/10428190109057959"},{"key":"10.3238\/arztebl.2010.0117_ref15","unstructured":"Wyen C, F\u00e4tkenheuer G, Hoffmann C: Die deutsche Lymphomkohorte-aktueller Stand. In: Hoffmann, J\u00e4ger (eds.): Aids 2008. Berlin, Wiley-Blackwell 2008"},{"key":"10.3238\/arztebl.2010.0117_ref16","doi-asserted-by":"crossref","unstructured":"Engels EA, Biggar RJ, Hall HI, et al.: Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008; 123: 187\u201394","DOI":"10.1002\/ijc.23487"},{"key":"10.3238\/arztebl.2010.0117_ref17","doi-asserted-by":"crossref","unstructured":"Rauch A, Gaudieri S, Evison J, et al.: Low current and nadir CD4+ T-cell counts are associated with higher hepatitis C virus RNA levels in the Swiss HIV cohort study. Antivir Ther 2008; 13: 455\u201360.","DOI":"10.1177\/135965350801300301"},{"key":"10.3238\/arztebl.2010.0117_ref18","doi-asserted-by":"crossref","unstructured":"Crum-Cianflone N, Hullsiek KH, Marconi V, et al.: Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. Aids 2009; 23: 41\u201350.","DOI":"10.1097\/QAD.0b013e328317cc2d"},{"key":"10.3238\/arztebl.2010.0117_ref19","doi-asserted-by":"crossref","unstructured":"Silverberg MJ, Neuhaus J, Bower M, et al.: Risk of cancers during interrupted antiretroviral therapy in the SMART study. Aids 2007; 21: 1957\u201363.","DOI":"10.1097\/QAD.0b013e3282ed6338"},{"key":"10.3238\/arztebl.2010.0117_ref20","doi-asserted-by":"crossref","unstructured":"Silverberg MJ, Chao C, Leyden WA, et al.: HIV infection and the risk of cancers with and without a known infectious cause. Aids 2009; 23: 2337\u201345.","DOI":"10.1097\/QAD.0b013e3283319184"},{"key":"10.3238\/arztebl.2010.0117_ref21","doi-asserted-by":"crossref","unstructured":"Clifford GM, Rickenbach M, Lise M, et al.: Hodgkin lymphoma in the Swiss HIV Cohort Study. Blood 2009; 113: 5737\u201342.","DOI":"10.1182\/blood-2009-02-204172"},{"key":"10.3238\/arztebl.2010.0117_ref22","doi-asserted-by":"crossref","unstructured":"Carbone A, Cesarman E, Spina M, Gloghini A, Schulz TF: HIV-associated lymphomas and gamma-herpesviruses. Blood 2009; 113: 1213\u201324.","DOI":"10.1182\/blood-2008-09-180315"},{"key":"10.3238\/arztebl.2010.0117_ref23","doi-asserted-by":"crossref","unstructured":"Diamond C, Taylor TH, Aboumrad T, Anton-Culver H: Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival. Cancer 2006; 106: 128\u201335.","DOI":"10.1002\/cncr.21562"},{"key":"10.3238\/arztebl.2010.0117_ref24","doi-asserted-by":"crossref","unstructured":"Berretta M, Cappellani A, Di Benedetto F, et al.: Clinical presentation and outcome of colorectal cancer in HIV-positive patients: a clinical case-control study. Onkologie 2009; 32: 319\u201324.","DOI":"10.1159\/000215719"},{"key":"10.3238\/arztebl.2010.0117_ref25","unstructured":"Mosthaf F: HIV-Infektion: J\u00e4hrliche Tumorvorsorge. Dtsch Arztebl 2004; 101: A 1074"},{"key":"10.3238\/arztebl.2010.0117_ref26","doi-asserted-by":"crossref","unstructured":"Ancelle-Park R: Expanded European Aids case definition. Lancet 1993; 341(8842): 441.","DOI":"10.1016\/0140-6736(93)93040-8"},{"key":"10.3238\/arztebl.2010.0117_ref27","doi-asserted-by":"crossref","unstructured":"Palefsky JM, Minkoff H, Kalish LA, et al.: Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999; 91: 226\u201336.","DOI":"10.1093\/jnci\/91.3.226"},{"key":"10.3238\/arztebl.2010.0117_ref28","doi-asserted-by":"crossref","unstructured":"Knowles DM: Etiology and pathogenesis of Aids-related non-Hodgkin\u2019s lymphoma. Hematol Oncol Clin North Am 2003; 17: 785\u2013820.","DOI":"10.1016\/S0889-8588(03)00050-9"},{"key":"10.3238\/arztebl.2010.0117_ref29","doi-asserted-by":"crossref","unstructured":"Capello D, Scandurra M, Poretti G, et al.: Genome wide DNA-profiling of HIV-related B-cell lymphomas. Br J Haematol 2010; 148: 245\u201355.","DOI":"10.1111\/j.1365-2141.2009.07943.x"},{"key":"10.3238\/arztebl.2010.0117_ref30","doi-asserted-by":"crossref","unstructured":"Simonelli C, Tedeschi R, Gloghini A, et al.: Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection. J Med Virol 2009; 81: 888\u201396.","DOI":"10.1002\/jmv.21349"},{"key":"10.3238\/arztebl.2010.0117_ref31","doi-asserted-by":"crossref","unstructured":"Carbone A, Gloghini A, Serraino D, Spina M: HIV-associated Hodgkin lymphoma. Curr Opin HIV Aids 2009; 4: 3\u201310.","DOI":"10.1097\/COH.0b013e32831a722b"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2010.0117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T14:22:31Z","timestamp":1661091751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2010.0117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,25]]},"references-count":31,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2010.0117","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,25]]}}}